In parallel, a series of transplantation assays in HCT116 xenograft mouse models showed that CD45 knockdown attenuated both primary and secondary tumor growth (Figure S5B), with a significant reduction in the tumor-repopulating potential (Figure 5E). Here, PTPRC is linked to neoplasm.